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Microinjection of foreignDNA inmale pronucleus by in-vitro embryomanipulation is difficult but remains
the method of choice for generating transgenic animals. Other procedures, including retroviral and
embryonic stem cell mediated transgenesis are equally complicated and have limitations. Although our
previously reported technique of testicular transgenesis circumvented several limitations, it involved many
steps, including surgery and hemicastration, which carried risk of infection and impotency. We improved
this technique further, into a two step non-surgical electroporation procedure, for making transgenic mice.
In this approach, transgene was delivered inside both testes by injection and modified parameters of
electroporation were used for in-vivo gene integration in germ cells. Using variety of constructs, germ cell
integration of the gene and its transmission in progeny was confirmed by PCR, slot blot and
immunohistochemical analysis. This improved technique is efficient, requires substantially less time and
can be easily adopted by various biomedical researchers.
M
ouse transgenesis is an important tool for functional genetics and for creating humanized models of
diseases. Transgenic animals can be produced by pronuclear DNAmicroinjection1,2, retroviral mediated
gene transfer3, embryonic stem cell based gene transfer4 and via somatic cell nuclear transfer5,6. Despite
the success of these procedures in generating genetically altered animals, these techniques are difficult to perform
and hence limited to selected laboratories having facilities and skilled personnel for embryo manipulation and
embryo transfer7. Intracytoplasmic sperm injection (ICSI) ormale germ cell mediated techniques of gene transfer
have also been reported in literature8–11. However, these techniques either require in vitro germ cell manipulation
followed by surgical germ cell transplantation or ICSI followed by embryo transfer in surrogates or surgical
manipulation to deliver DNA in the testis followed by electroporation of DNA in the spermatogonia. All of these
methods involve surgical steps which can potentially cause infection and/or impotency. Therefore there is a need
to develop relatively safer and a less time consuming procedure for transgenesis.
Testicular transgenesis has advantage over zygote or oocyte mediated transgenesis because this does not
require large number of females for super ovulation and expertise for embryo manipulation. To ensure easy
adaptability of our previously reported testicular transgenesis technique, we improved the technique into a two
step non-surgical electroporation procedure for making transgenic mice. We standardized the technique using
construct having Enhanced Green Fluorescence Protein (EGFP) as the reporter. Subsequently, we also generated
transgenic lines of mice using different constructs including those for tissue specific expression and those
displaying patho-physiological effect of the transgene. This is the first report of non-surgical approach for in
vivo germline integration of foreign gene and efficient generation of transgenic mice without using any assisted
reproductive technique (ART). This procedure can be potentially adopted for transgenesis in farm animals where
surgery as well as embryo transfer are not as easy as those in mice.
Results
Establishment of the technique for non-surgical in-vivo electroporation of the testis. Linearised pCX-EGFP
plasmid (Fig. 1a-i) was used for standardization of the technique; one testis was injected with the DNA and the
contra-lateral testis was kept as control (non-injected). Various DNA injection parameters such as amount of DNA
(ranging from 10 mg–30 mg per testis), volume of suspended DNA (ranging from 20–25 ml) injected per testis,
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electroporation parameters such as voltage (ranging from 50 V–
90 V), time constant (ranging from 10 ms–60 ms) and number of
pulses were varied to determine the most optimum condition for gene
integration in the spermatogonial cells of testis (Table 1).
Desirable results were obtained in the combination of steps
described in EP12 (Table 1) where efficient transgene integration
and expression in the testis was achieved by injecting 20 ml of linear-
izedDNA suspension (0.5 mg/ml) into testis of about 30 days oldmice
Figure 1 | (a): Schematic diagram of the various constructs used in the study: i) pCX-EGFP plasmid. (ii) PEPCK1-IRES2-EGFP plasmid. (iii) K14-IRES2-
EGFP plasmid. (iv) SMAR1-EGFP plasmid. (b): Schematic representation of the non-surgical external in-vivo testicular electroporation procedure. (i)
represents the anaesthetized mice; (ii) shows the DNA injection in one of the testis from two different sites; (iii) shows the DNA injection in remaining
testis; (iv) shows the electroporation in both the testes, held together, using tweezer type electrode; (v) shows the electroporation by changing the poles
(red and black) of the tweezer type electrode after 4 pulses.
www.nature.com/scientificreports
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before electroporating germ cells with 4 square 60 V electric pulses
(duration of 50 milli-seconds each with an inter-pulse interval of
approximately one second) in one direction (forward direction)
and 4 more similar pulses after changing the sides of the electrodes
(reverse direction; Fig. 1b and Table 1). Electroporated testis
expressed EGFP even at 80 days of age (Fig. 2a & Fig. 2b). GFP
expressing germ cells were discernible in the seminiferous tubules
of all 4 such pCX-EGFP electroporated mice (Fig. 2c).
Generation of transgenic mice for tissue specific expression of
transgene. We also investigated whether the optimized procedure
can generate transgenic progeny when tissue specific expression
cassette was used. For this, we electroporated testicular germ cells
with pK14-IRES2-EGFP construct in which EGFP expression was
driven by promoter of skin specific protein, keratin 14 (K14) and
with pPEPCK1-IRES2-EGFP construct, in which EGFP expression
was driven by the promoter of liver specific phosphoenolpyruvate
carboxykinase 1 (PEPCK1). In case of both constructs, transmission
of transgene from electroporated mice (fore-founder) to several of
their progeny was discerned by PCR analysis. PCR results (data not
shown) were further confirmed by slot-blot analysis where the
IRES2-EGFP region of the transgene (Fig. 1a-ii & iii) was detected
with aP32 labelled probe (Fig. 3a & 3b). One of the pK14-IRES2-
EGFP fore founder mice sired transgenic progeny even after 274
days of electroporation. Integration of pK14-IRES2-EGFP
transgene in germ cell was also confirmed by fluorescence in situ
hybridization of sperm from epididymis of electroporated mice
(Fig. 3c). Expression of EGFP was detected specifically in the
epidermis of the skin of pK14-IRES2-EGFP transgenic progeny
(Fig. 4a). Similarly, EGFP expression was also detected in the cross
section of the liver (Fig. 4b) of pPEPCK1-IRES2-EGFP transgenic
progeny.
Generation of transgenic mice displaying patho-physiological
effect. We used pEGFP-SMAR1construct (Fig. 1a-iv) for making
fore-founders which were cohabitated with wild type females.
Presence of transgene in progeny was determined by PCR analysis
(data not shown). Over-expression of Scaffold/Matrix attachment
region binding protein1 (SMAR1) caused splenomegaly in
transgenic mice (Fig. 5a & 5b). We also detected EGFP expression
in the cross section of spleen (Fig. 5c) obtained from pEGFP-
SMAR1transgenic mice.
Discussion
Presently used techniques for generation of transgenic mice exploit-
ing spermatogonial cells require in vitro germ cell culture and/or
various surgical steps which are difficult to adopt10,12. We have sub-
stantially improved the procedure of in vivo testicular transgenesis
making it an easily adaptable, user friendly technique. In the hands of
a person who is less experienced in performing surgery, surgical
intervention in the vicinity of the reproductive area is prone to
development of impotency or post surgical infection in the animals.
Unlike surgical exposure of one of the testis for DNA injection fol-
lowed by removal of contra-lateral testis, as described by us before11,
in the present procedure, suspension of gene was delivered in both
testes of mice directly from outside followed by electroporation
(Supplementary Fig. S1). Simultaneous electroporation and gene
integration in both testes by holding them together at the time of
electroporation precluded the need of hemicastration as required for
previously reported procedure11. As compared to this new technique,
the previously reported procedure where electroporation of testis
followed surgical exposure had several drawbacks (Table 2).
Expression of EGFP in the electroporated testis about a month and
a half after electroporation with pCX-EGFP, confirmed genomic
integration of the transgene. The improved procedure resulted in
integration of the transgene, largely in germ cells of the seminiferous
tubule. Validation of the technique was done using different mam-
malian gene constructs. Electroporation with this chosen set of
parameters (60 v/50 ms, 4 pulses each in forward and reverse dir-
ection with inter pulse interval of 1 second) did not alter the cyto-
architecture of the testis, the normalcy of which is crucial for
spermatogenesis13.
To determine the suitability of this procedure for tissue specific
gene expression, we designed pK14-IRES2-EGFP and pPEPCK1-
IRES2-EGFP constructs for expression of EGFP in skin and liver,
respectively. Fore-founder mice were generated using these con-
structs and cohabitated with wild type females after 35 days post
electroporation. In mice, differentiation of spermatogonia into
sperm occurs in about 35 days10,14,15. Generation of transgenic pro-
geny from mating after 35 days of electroporation suggested that
spermatogonial cells were successfully transfected at the time of elec-
troporation. Detection of transgene in the epididymal sperm of elec-
troporated male by fluorescence in situ hybridization provided
substantial evidence in favour of germ line gene integration upon
external electroporation of testis. F1 progeny obtained upon mating
Table 1 | Electroporation parameters used while optimizing non-surgical in vivo testicular electroporation using linearized pCX-EGFP
plasmid
DNA parameters EP parameters
Electroporation condition Conc. (mg/ml) Vol./Testis (ml) Amt. (mg) Voltage (V) i (ms) No. F 1 R
EP1 0.5 20 10 90 30 4 1 4
EP2 0.5 20 10 80 20 4 1 4
EP3 0.5 20 10 80 30 4 1 4
EP4 0.5 25 12.5 80 40 2 1 2
EP5 1.0 25 25 50 50 4 1 4
EP6 1.0 25 25 50 30 4 1 4
EP7 1.0 25 25 50 20 8
EP8 1.2 25 30 70 50 4 1 4
EP9 1.2 25 30 70 30 4 1 4
EP10 1.2 25 30 70 10 4 1 4
EP11 0.5 20 10 60 20 4 1 4
EP12 0.5 20 ml 10 mg 60 V 50 ms 4 1 4
EP13 0.5 20 10 60 30 4 1 4
EP14 0.5 20 10 60 60 4 1 4
Abbreviations used. Conc.: concentration, Vol.: volume, Amt.: amount, EP: electroporation, i: time constant, No.: number of pulses, F: forward direction. R: reverse direction. EP12 depicts the most
optimum condition of efficient non-surgical electroporation used in the study.
www.nature.com/scientificreports
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of fore-founders were checked for the presence of transgene. Several
pups were found to be PCR positive for the transgene. This indicated
the transmission of integrated transgene to the next generation. We
confirmed these PCR results by slot blot analysis. Genomic DNA of
PCR positive progeny were probed with IRES2-EGFP fragment
(Fig. 1a-ii & iii) labeled with radioactive aP32. Please note that
IRES2-EGFP was the part of both pK14-IRES2-EGFP and
pPEPCK1-IRES2-EGFP constructs. Slot blot positive male and
female mice of F1 generation were bred to generate F2 generation
and so on.
Immunohistochemical analysis of skin from F1 progeny of pK14-
IRES2-EGFP transgenic mice strongly displayed the specific express-
ion of EGFP in the epidermal layer of skin. Use of K14 promoter for
skin specific expression of genes is well documented and our results
were similar to those reported previously for such transgenic animals
bearing K14 promoter driven genes which were generated using
traditionally used pronuclear DNA microinjection method16–18.
Similarly, immunohistochemical analysis of liver sections of
pPEPCK1-IRES2-EGFP transgenic mice revealed expression of
transgene (EGFP) predominantly in the liver, as reported before
using traditional procedure of transgenesis19. These observations
suggested that this new technique is capable of generating transgenic
mice with tissue specific targeted gene expression.
To explore the possibility of making animal models showing
patho-physiological condition, we generated transgenic mice by this
procedure using pEGFP-SMAR1 construct. SMAR1 is the MAR
binding protein that functions as a candidate tumor suppressor by
interacting with and activating p53, thereby regulating cell cycle20.
Please note that SMAR1 is also expressed endogenously21. In this
study, transgenic mice carrying pEGFP-SMAR1 had enlarged spleen
which over expressed SMAR1-EGFP fusion protein; this was similar
to presence of enlarged spleen in SMAR1 transgenic mice, tradition-
ally made using male pronuclear DNA microinjection22. Observa-
tions from pEGFP-SMAR1 transgenic mice made by this new
technique confirmed that transgene was stably integrated and trans-
mitted to the next generation with visible patho-physiological effect
(enlargement of spleen).
In summary, generation of transgenic mice by non-surgical,
external testicular electroporation resulted in the germ line integ-
ration of the transgene. All electroporated male mice successfully
produced litters among which several were transgenic. This proced-
ure required less period of sedation and less time as compared to
previously reported procedures1,8,11. The percentage of F1 progeny
bearing transgene was about 57%–62%, using various types of gene
constructs used in this study (Table 3). This is remarkably higher
than Pronuclear DNA microinjection mediated transgenesis where
10%–20% of attempted progeny are PCR positive for the transgene7
making our technique relatively more efficient. All four animals elec-
troporated with pCX-EGFP construct expressed EGFP in the testicu-
lar tissue. Similarly each of 4 slot blot positive animals of F1
Figure 2 | EGFP expression in mouse testis, 50 days after electroporation. (a). Image in bright field stereozoom microscope. (b). Image under FITC
filter of stereozoom microscope. In the area injected with DNA, EGFP expression is marked with yellow line. (c). EGFP expression in germ cells of
seminiferous tubules of electropoarated testis upon staining with anti EGFP antibody. Yellow arrow heads show staining in germ cells. Note: EP –
electroporated testis; NEP – Non-electroporated testis.
www.nature.com/scientificreports
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generation showed presence of EGFP in organs for which specific
promoters were used. This modified technique is simple, less time
consuming and ethically superior than our previously described pro-
cedure as it uses mild anesthesia for short duration and does not
require hemicastration or any other surgical interventions or sacrifice
for transgenesis. Since cumbersome surgical steps or assisted repro-
ductive techniques are not involved, several fore-founders can be
generated with minimum effort using various constructs by this pro-
cedure. Right and left testes of an animal can also be independently
used for transfecting two different kinds of gene constructs which can
further reduce (by half) the production time for generation of two
different transgenic lines. We used FVB/J strain of mice, however,
minor procedural variations (for eg. different concentration of DNA
or moderate variation in current used) may be required while using
other strains of mice. A large variety of mice carrying different trans-
genes can be generated within short span of time using this 2 step
short-cut method (DNA injection and external electroporation).
Such a simple non-surgical technique may also potentially increase
the scope of generating transgenic farm animals with desirable traits.
Methods
Animals. Mice (FVB/J), bred at the small animal facility of National Institute of
Immunology, were used for the present study. All animals were kept at 24 6 2uC
under 14 h light and 10 h dark cycle and used as per theNational Guidelines provided
by the Committee for the Purpose of Control and Supervision of the Experiments on
Animals (CPCSEA). Protocols for the experiments were approved by the Institutional
Animal Ethics Committee.
Constructs. pCX-EGFP. This plasmid contains functional chicken beta actin
promoter along with cytomegalovirus transcription enhancer element (CX) as a
strong ubiquitous transcription regulator. A functional EGFP gene is cloned under
this promoter assembly which yields a strong ubiquitous EGFP expression (Fig. 1a-i).
This plasmid was linearized with Sal I restriction enzyme before used for the
standardization of the technique.
pPEPCK1-IRES2-EGFP. The promoter for the cytosolic variant of phosphoenolpyr-
uvate carboxykinase 1(PEPCK1) was PCR amplified from mice genome employing
high fidelity Pfu DNA polymerase (Fermentas, Pittsburgh, PA, USA). The PCR
condition included initial denaturation at 95uC for 4 min followed by 29 cycles of
95uC for 45 s, 64uC for 45 s, 72uC for 1 min with final extension of 72uC for 10 min;
resulting in 1037 bp amplicon. Primers employed for amplifying the promoter were
Forward: 59-CTCCCCTCCTTTCTCCAGACAC-39 and Reverse: 59-
GAAGGTCTGGATCCGAGATCGC-39. The amplicon was ligated into pIRES2-
EGFP vector (Clontech, Mountain View, CA, USA) to generate the plasmid
pPEPCK1-IRES2-EGFP (Fig. 1a-ii). After plasmid amplification, construct was
digested with EcoRI and AflII and the desired linearized fragment (,2.6 kb), con-
taining promoter and the gene, was purified using gel extraction kit (Qiagen, Hilden,
Germany) before it was used for electroporation.
pK14-IRES2-EGFP. The promoter region for human keratinocyte specific protein
(K14) was amplified using long PCR employing high fidelity Pfu DNA polymerase
Figure 3 | Determination of transgene integration by slot blot analysis. (a): P4& P6 (F1 of Ext 21); P19–P21 (F1 of Ext 22); P25–P33 (F2 of P6); P34–P49
(F2 of P4). Wt1–Wt5 gDNA from five different wild type mice. (b): K1–K8 (F1 of Ext 17); K12–21 (F1 of Ext 18); K23–K28 (F2 of K17); K33–67 (F2 of
K18). Wt1–Wt5 represents gDNA from five different wild type mice. The gDNA were probed with labelled IRES2-EGFP fragment as all of the lines
mentioned above contained IRES2-EGFP. The same fragment was used as positive control in both the blots.Note: K denotes transgenic animal of pK14-
IRES2-EGFP line; P denotes transgenic animal of pPEPCK1-IRES2-EGFP line; WT denotes wild type mice. 1ve denotes plasmid DNA fragment. Ext
denotes the respective fore-founder mice. F1 and F2 denote first and second generation of progeny respectively. (c): Fluorescence in situ hybridization of
the sperm from pK14-IRES2-EGFP electroporated mice. Green signal is seen in sperm nuclei due to hybridization of probe with pK14-IRES2-EGFP
transgene and blue signal displays DAPI staining of nucleus. Field under observation shows two transgenic sperm and two non transgenic sperm. (i) Phase
contrast image. (ii) Image under UV. Scale bar, 20 mm.
www.nature.com/scientificreports
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Figure 5 | (a & b): Enlarged spleen of the mice transgenic for Egfp-Smar1 (left) as compared to wild type mice (right); Tg1, Tg2 and Tg3 denote enlarged
spleen of three different transgenic mice andWT1 andWT2 denote normal spleen of two different wild type mice. (c): EGFP expression in the spleen of
pSMAR1-EGFP transgenicmice stainedwith anti EGFP antibody. (i & ii) immunohistochemical images of spleen sections from the transgenicmice. (iii &
iv) immunohistochemical images of the spleen section from thewild typemice. Left panel shows the phase contrast image and right panel shows the image
under UV with FITC filter. Scale bar, 20 mm (i–iv).
Figure 4 | (a): EGFP expression in the skin of pK14-IRES2-EGFP transgenic mice stained with anti EGFP antibody. (i & ii) immunohistochemical images
of the skin sections of the transgenic mice. (iii & iv) immunohistochemical images of the skin sections of wild type mice. Left panel shows the phase
contrast image and right panel shows the image under UV with FITC filter. Scale bar: 50 mm (i–ii); 100 mm (iii–iv). (b): EGFP localization in the liver of
pPEPCK1-IRES2-EGFP transgenic mice stained with anti EGFP antibody. (i & ii) immunohistochemical images of the liver sections of the transgenic
mice. (iii & iv) immunohistochemical images of the liver section of wild type mice. Left panel shows the phase contrast image and right panel shows the
image under UV with FITC filter. Scale bar, 50 mm (i–ii) & 20 mm (iii–iv).
www.nature.com/scientificreports
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(Fermentas, Pittsburgh, PA, USA) from human genomic DNA isolated from blood.
Primers used for amplification of 2486 bp upstream region of K14 gene were
Forward: 59-AACCCTTTAACCCCTGATGC-39 and Reverse: 59-
GTGCAGAGGAGGGAGGTGAG-39. PCR condition included initial denaturation
of 4 min at 95uC followed by 29 cycles of 45 s at 95uC, 45 s at 63uC, 3 min at 72uC
with a final extension at 72uC for 10 min. The,2.5 kb amplicon thus obtained was
ligated into pIRES2-EGFP vector (Clontech, Mountain View, CA, USA) to generate
plasmid pK14-IRES2-EGFP (Fig. 1a-iii). After plasmid amplification, this construct
was digested with EcoRI and AflII and the desired linearized fragment (,4.1 kb) was
purified using gel extraction kit (Qiagen, Hilden, Germany) before it was used for
electroporation.
pEGFP-SMAR1. This fusion gene construct consisted of full-length fragment of
Scaffold/Matrix attachment region binding protein1 (SMAR1) as described before23
where EGFP which was cloned downstream of cytomegalovirus immediate early
promoter/enhancer of pEGFP-C3 vector (Clontech, Mountain View, CA, USA). For
testicular injection, the plasmid was digested withXbaI andApaLI restriction enzyme
(Fig. 1a-iv). Two fragments were generated, one of,4 kb and the other of,3.2 kb.
The 3.2 kb fragment which had CMV at the 59 end and SMAR1 at 39 end was used for
electroporation.
Non-surgical in vivo injection and electroporation of mice testis. For this purpose,
about 30 days old male mice (FVB/J) were anesthetized for short duration by
intraperitonial injection (100 ml) of ketamine hydrochloride (45 mg/kg) and xylazine
hydrochloride (8 mg/kg). After removing hair from lower abdominal and scrotal
region, area was cleaned with betadine (povidone-iodine) solution. Subsequently,
sterile water was spread on scrotal area to remove excess betadine. Plasmid DNA
containing 0.04% Trypan blue, which was used to monitor the accuracy of the
injection, was injected slowly into the testis using the 10 ml Hamilton syringe (701N;
Hamilton Bonaduz AG, Switzerland) from two different, diagonally opposite sites.
DNA was delivered through one injection site at a time (Fig. 1b). Usually, needle of
Hamilton syringe is long and tends to bend because of the resistance posed by the
scrotal sac. Therefore, a small (0.5 inch long) 26 gauge sterile needle (usually supplied
with tuberculin syringe) was slowly inserted up to middle of the testis and withdrawn
to generate path for introducing the needle of a Hamilton syringe. For
standardization, about 20 ml–25 ml of sterile water containing the desired plasmid
DNA (concentration ranging from 0.5 mg/ml–1.2 mg/ml) was delivered unilaterally
into a testis. Mild square electric pulses ranging from 50 V to 90 V were delivered to
testis injected with DNA using tweezer type electrode and an electric pulse generator
(Electroporator ECM2001, BTX Instrument Division, Harvard Apparatus, Inc.,
Holliston, Massachusetts, USA). Variation in several parameters like voltage, time
constant (duration of the pulse), number of pulses and number of injection sites were
done at the time of electroporation to determine the most suitable condition for
achieving a successful and stable gene integration in germ cell of the testis (Table 1).
Sterile normal saline was spread occasionally on scrotum to keep the skin moist for
uniform electrical conductance during the procedure.
For generating transgenic lines using various constructs, DNAwas injected in both
testes of every animal and testes were held together between a sterile tweezer-type
electrode for their simultaneous electroporation.
Analysis of electroporated testis under stereozoom microscope. pCX-EGFP
electroporated male mice were sacrificed by cervical dislocation after 50 days of
electroporation. Testes were observed under a stereo-zoom microscope SMZ-1500
(Nikon Corporation, Chiyoda-ku, Tokyo, Japan) fitted with epi-fluorescence
attachment. Images were captured using DS-5M camera with Digital sight DS-LI
software.
Propagation of the transgene & PCR based screening. The electroporated males
(fore-founders) were cohabitated with wild-type females, 35 days post-
electroporation and the pups generated (F1 generation) were analyzed for the
presence of transgene by PCR. F2 generations of mice were generated by breeding
PCR positive males and females from F1 generation.
Slot blot analysis.The results of PCRwere further confirmed by Slot blot analysis24 of
few PCR-positive animals from each generation. Transgene specific probe was
generated with aP32dCTP using High Prime DNA labeling kit (Roche Diagnostic
GmbH, Mannheim, Germany). About 1 mg of gDNA was blotted on membrane and
hybridized with transgene specific probe for detection of transgene in the progeny.
Immunohistochemistry. Expression of EGFP in the cross section of the testis of
pCX-EGFP transgenicmice, spleen of pEGFP-SMAR1 transgenicmice, skin of pK14-
IRES2-EGFP transgenic mice and liver of pPEPCK1-IRES2-EGFP transgenic mice
was detected by immuno-histochemistry. Tissue samples were fixed in Bouin’s
solution for 18–24 h, and then embedded in paraffin. Tissue sections (4micron) were
stained with mouse anti-GFP (Clontech, Mountain View, CA, USA) antibody at
15250 dilution for 10 hrs at 4uC. Alexa fluor 488 conjugated goat anti mouse IgG
(Molecular probes, Eugene, OR, USA) was used as secondary antibody at 15250
dilution for 4 hrs at room temperature for the detection of specific protein. Stained
sections were analyzed under Zeiss LSM 510 META confocal laser-scanning
microscope (Zeiss, Jena, Germany) and LSM 510 software was used for acquisition of
images. Images were also captured using Nikon Eclipse TE2000-S inverted
microscope (Nikon Corporation, Chiyoda-ku, Tokyo, Japan) attached to DS-5 M
camera assisted with digital sight DS-L1 software.
Fluorescence in situ hybridization. For fluorescence in situ hybridization, sperm
from pK14-IRES2-EGFP electroporated mouse were taken from cauda epididymis
and washed in PBS; sperm nuclei were prepared as described previously25. pK14-
IRES2-EGFP plasmid was labeled with green dUTP using the Vysis nick translation
kit (Abott Molecular Inc., Des Plaines, IL, USA) and used as probe. In situ
hybridization was performed as described previously25. The fluorescence was
observed under Nikon Eclipse Ti inverted fluorescence microscope (Nikon
Corporation, Chiyoda-ku, Tokyo, Japan). The images were captured using Nikon-
digital sight DS-Ri1 camera.
1. Gordon, J. W., Scangos, G. A., Plotkin, D. J., Barbosa, J. A. & Ruddle, F. H. Genetic
transformation of mouse embryos by microinjection of purified DNA. Proc. Natl.
Acad. Sci. 77, 7380–7384 (1980).
2. Palmiter, R. D. et al. Dramatic growth of mice that develop from eggs
microinjected with metallothionein-growth hormone fusion genes. Nature 300,
611–615 (1982).
3. Van der, P. H. et al. Efficient insertion of genes into the mouse germ line via
retroviral vectors. Proc. Natl. Acad. Sci. 82, 6148–6152 (1985).
4. Beard, C., Hochedlinger, K., Plath, K., Wutz, A. & Jaenisch, R. Efficient method to
generate single-copy transgenic mice by site-specific integration in embryonic
stem cells. Genesis 44, 23–28 (2006).
Table 2 | Advantages of non-surgical testicular transgenesis
Surgical Testicular electroporation* Non-surgical testicular electroporation
Surgical exposure of the testis Yes No
Hemiscastration Yes No
Anitibiotic treatment required for 7 days Not required (apply betadiene post procedure)
Duration of the procedure 45 min–50 min 10 min
Physical contact of electrodes with body fluid Yes No
Possibility of post surgical infection High Nil
Chances of impotency Yes Nil
Extrapolation of the technique to large farm animals Not feasible Feasible
* Previously Reported.
Table 3 | Transgenic efficiency of non-surgical, testicular external
electroporation technique
Constructs
pK14-IRES2-
EGFP
pPEPCK-IRES2-
EGFP pEGFP-SMAR1
No. of animals
Electroporated
(Fore Founders)
4 (Ext17, Ext18,
Ext19, Ext20)
4 (Ext21, Ext22,
Ext23, Ext24)
4 (EP16, EP17,
EP18, EP19)
Siring Ability All 4 Animal
Sired Pups
All 4 Animal
Sired Pups
All 4 Animal
Sired Pups
No. of progeny sired 62 53 67
No. of progeny
carrying transgene
37 33 38
Note: Ext and EP represent various fore-founder animals.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 3 : 3430 | DOI: 10.1038/srep03430 7
5. Cibelli, J. B. et al. Cloned transgenic calves produced from non quiescent fetal
fibroblasts. Science 280, 1256–1258 (1998).
6. Baguisi, A. et al. Production of goats by somatic cell nuclear transfer. Nat
Biotechnol. 17, 456–461 (1999).
7. Wall, R. J. Pronuclear microinjection. Cloning stem cells. 3, 209–220 (2001).
8. Perry, A. C. et al. Mammalian transgenesis by intracytoplasmic sperm injection.
Science 284, 1180–1183 (1999).
9. Nagano, M. et al. Transgenic mice produced by retroviral transduction of male
germ-line stem cells. Proc. Natl. Acad. Sci. 98, 13090–13095 (2001).
10. Brinster, R. L. Germline stem cell transplantation and transgenesis. Science 296,
2174–2176 (2002).
11. Dhup, S. & Majumdar, S. S. Transgenesis via permanent integration of genes in
repopulating spermatogonial cells in vivo. Nature Methods 5, 601–603 (2008).
12. Kanatsu-Shinohara, M. et al. Long-term proliferation in culture and germline
transmission of mouse male germline stem cells. Biol Reprod. 69, 612–616 (2003).
13. Je´gou, B. The Sertoli-germ cell communication network in mammals. Int. Rev.
Cytol. 147, 25–96 (1993).
14. Russell, L. D., Ettlin, R. A., Sinha Hikim, A. P. & Clegg, E. D. [Mammalian
spermatogenesis] Histological and Histopathological Evaluation of the Testis
[Russell, L. D. & Ettlin, R. A. (1st ed.)] [1–40] (Cache River Press, Clearwater,
Florida, 1990).
15. de Rooij, D. G. & Russell, L. D. All you wanted to know about spermatogonia but
were afraid to ask. J. Androl. 21, 776–798 (2000).
16. Wang, X., Zinkel, S., Polonsky, K. & Fuchs, E. Transgenic studies with a keratin
promoter driven growth hormone transgene: prospects for gene therapy. Proc.
Natl. Acad. Sci. 94, 219–226 (1997).
17. Fuchs, E. & Green, H. Changes in keratin gene expression during terminal
differentiation of the keratinocytes. Cell 19, 1033–1042 (1980).
18. Stellmach, V., Leask, A. & Fuchs, E. Retinoid-mediated transcriptional regulation
of keratin genes in human epidermal and squamous cell carcinoma cells. Proc.
Natl. Acad. Sci. 88, 4582–4586 (1991).
19. McGrane, M. M. et al. Tissue specific expression and dietary regulation of a
chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in
transgenic mice. J. Biol. Chem. 263, 11443–11451 (1988).
20. Kaul, R. et al. Direct interaction with and activation of p53 by SMAR1 retards cell-
cycle progression at G2/M phase and delays tumor growth in mice. Int. J. Cancer
103, 606–615 (2003).
21. Chattopadhyay, S., Kaul, R., Charest, A., Housman, D. &Chen, J. SMAR1, a novel,
alternatively spliced gene product, binds the Scaffold/Matrix-associated region at
the T cell receptor beta locus. Genomics 68, 93–96 (2000).
22. Kaul-Ghanekar, R. et al. Abnormal V(D)J recombination of T cell receptor beta
locus in SMAR1 transgenic mice. J. Biol. Chem. 280, 9450–9459 (2005).
23. Chattopadhyay, S., Whitehurst, C. E., Schwenk, F. & Chen, J. Biochemical and
functional analyses of chromatin changes at the TCR-beta gene locus during
CD4-CD8- to CD4 1 CD81 thymocyte differentiation. J. Immunol. 160,
1256–1267 (1998).
24. Brown, T. [Dot and slot blotting of DNA] Current Protocols in Molecular Biology.
[Brown, T.] [21: 2.9.15–2.9.20] (John Wiley and Sons, Hoboken, 2001).
25. Iba´n˜ez, E., Molist, J., Vidal, F., Egozcue, J. & Santalo´, J. Assessment of the
proportion of transgene-bearing sperm fluorescence in situ hybridization: a novel
approach for the detection of germline mosaicism in transgenic male founders.
Mol Reprod Dev. 58, 166–172 (2001).
Acknowledgments
We are grateful to the Director of National Institute of Immunology for her support.We are
thankful to Dr S. Chattopadhyay (National Center for Cell Science, Pune, India) for
providing the SMAR1-EGFP gene construct. We are also grateful to Dr. Y. Junming
(University of Tennesse,Memphis, USA) for giving us the pCX-EGFP construct.We greatly
acknowledge the technical support from Birendra N. Roy, Dharamveer and Ram Singh.We
acknowledge the help from staff of Small Animal Facility of National Institute of
Immunology. We are grateful to Department of Biotechnology, Govt. of India, for
providing the financial assistance under grants BT/PR11313/AAQ/01/376/2008 and BT/
HRD/35/01/01/2010 (TATA Innovation Award).
Author contributions
Experiments were conceived and designed by S.S.M. Experiments were performed by A.U.,
N.G., H.S., S.D., S.R.B., M.V., N.G., S.B. and P.N. Data of the manuscript was analyzed by
A.U., N.G. and S.S.M. Manuscript was written and reviewed by A.U., N.G. and S.S.M.
Additional information
Supplementary information accompanies this paper at http://www.nature.com/
scientificreports
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Usmani, A. et al. A non-surgical approach for male germ cell
mediated gene transmission through transgenesis. Sci. Rep. 3, 3430; DOI:10.1038/
srep03430 (2013).
This work is licensed under a Creative Commons Attribution-
NonCommercial-NoDerivs 3.0 Unported license. To view a copy of this license,
visit http://creativecommons.org/licenses/by-nc-nd/3.0
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 3 : 3430 | DOI: 10.1038/srep03430 8
